Pharma

Your Article Summary

See Latest Articles

ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09

ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced today that presentations of clinical data for three product candidates employing its Targeted Antibody Payload technology will be made at the 51st American Society of Hematology Annual Meeting and Exposition to be held in New Orleans, LA, on December 2009.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Protox Announces Private Placement
Protox Therapeutics , 02/08/10

Repligen Receives Notice of Allowance for Recombinant Protein A Patent
Repligen, 02/04/10

Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A
Repligen, 01/29/10

 See all of Biotechnology

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Human genome sciences invites investors to listen to webcast of presentation at bio ceo investor conference
Human Genome Sciences, 02/08/10

Fujifilm Offers Grants for Residents to Attend ARRS Meeting
Imaging Economics, 02/05/10

Notice of Conference Call and Webcast: Fourth Quarter and Year End 2009 Financial Results
Angiotech Pharmaceuticals, 02/05/10

 See all of Conferences/Meetings